These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 31329849)

  • 21. The effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure.
    Rørth R; Thune JJ; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Bruun NE; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Kristensen SL
    Europace; 2019 Aug; 21(8):1203-1210. PubMed ID: 31323662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of appropriate anti-tachycardia therapies after elective generator replacement in patient with heart failure initially implanted with a defibrillator for primary prevention: Results of a meta-analysis.
    Rordorf R; Cornara S; Klersy C; Savastano S; Vicentini A; Sanzo A; Petracci B; Ghio S; Oltrona Visconti L; De Ferrari GM
    Int J Cardiol; 2019 May; 283():122-127. PubMed ID: 30638746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.
    Blom LJ; Visser M; Christiaans I; Scholten MF; Bootsma M; van den Berg MP; Yap SC; van der Heijden JF; Doevendans PA; Loh P; Postema PG; Barge-Schaapsveld DQ; Hofman N; Volders PGA; Wilde AA; Hassink RJ
    Europace; 2019 Oct; 21(10):1519-1526. PubMed ID: 31114860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between socioeconomic factors and ICD implantation in a publicly financed health care system: a Danish nationwide study.
    Winther-Jensen M; Hassager C; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Christensen EF; Kragholm K; Kjaergaard J
    Europace; 2018 Jul; 20(7):1129-1137. PubMed ID: 29016817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term benefit of implantable cardioverter/defibrillator therapy after elective device replacement: results of the INcidence free SUrvival after ICD REplacement (INSURE) trial--a prospective multicentre study.
    Erkapic D; Sperzel J; Stiller S; Meltendorf U; Mermi J; Wegscheider K; Hügl B;
    Eur Heart J; 2013 Jan; 34(2):130-7. PubMed ID: 22771679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
    Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
    Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication.
    Boersma LV; Barr CS; Burke MC; Leon AR; Theuns DA; Herre JM; Weiss R; Kremers MS; Neuzil P; Husby MP; Carter N; Stivland TM; Gold MR;
    Heart Rhythm; 2017 Mar; 14(3):367-375. PubMed ID: 27890798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Olesen LL; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Thune JJ
    Circulation; 2017 Nov; 136(19):1772-1780. PubMed ID: 28877914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Charlson comorbidity index to predict early mortality in implantable cardioverter defibrillator patients.
    Bhavnani SP; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Ann Noninvasive Electrocardiol; 2013 Jul; 18(4):379-88. PubMed ID: 23879278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.
    Özcan C; Raunsø J; Lamberts M; Køber L; Lindhardt TB; Bruun NE; Laursen ML; Torp-Pedersen C; Gislason GH; Hansen ML
    Europace; 2017 Jun; 19(6):1007-1014. PubMed ID: 28073883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries.
    Sticherling C; Arendacka B; Svendsen JH; Wijers S; Friede T; Stockinger J; Dommasch M; Merkely B; Willems R; Lubinski A; Scharfe M; Braunschweig F; Svetlosak M; Zürn CS; Huikuri H; Flevari P; Lund-Andersen C; Schaer BA; Tuinenburg AE; Bergau L; Schmidt G; Szeplaki G; Vandenberk B; Kowalczyk E; Eick C; Juntilla J; Conen D; Zabel M;
    Europace; 2018 Jun; 20(6):963-970. PubMed ID: 29016784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter-defibrillator therapy and device-related complications in young patients with inherited cardiomyopathies or channelopathies: a 17-year cohort study.
    Petersen LDD; Christiansen MK; Pedersen LN; Nielsen JC; Broendberg AK; Jensen HK
    Europace; 2018 Nov; 20(11):1849-1855. PubMed ID: 29697814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early mortality after implantable cardioverter defibrillator: Incidence and associated factors.
    Garcia R; Boveda S; Defaye P; Sadoul N; Narayanan K; Perier MC; Klug D; Fauchier L; Leclercq C; Babuty D; Bordachar P; Gras D; Deharo JC; Piot O; Providencia R; Marijon E; Algalarrondo V;
    Int J Cardiol; 2020 Feb; 301():114-118. PubMed ID: 31753583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life.
    Merchant FM; Jones P; Wehrenberg S; Lloyd MS; Saxon LA
    J Am Heart Assoc; 2014 Nov; 3(6):e001289. PubMed ID: 25385346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism in patients with implantable cardioverter-defibrillators.
    Pedersen SB; Hjortshøj SP; Bøtker HE; Farkas DK; Schmidt M; Sørensen HT; Nielsen JC
    Europace; 2017 Jun; 19(6):991-1001. PubMed ID: 27256414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.